top of page

Home
Solutions
Treatment Selection
LiquidHALLMARK®
LiquidHALLMARK® CSF
Screening & Health Risk Assessment
CardioHemeRISK™
LucenceINSIGHT™
Treatment Selection
LiquidHALLMARK®
LiquidHALLMARK® CSF
Screening & Health Risk Assessment
CardioHemeRISK™
LucenceINSIGHT™
Communities
Oncologists
Patients
Insurers
Investors
Oncologists
Patients
Insurers
Investors
Knowledge Center
News & Updates
Clinical Insights
Publications
Patient Stories
Webinars
Case Studies
News & Updates
Clinical Insights
Publications
Patient Stories
Webinars
Case Studies
About Us
About Lucence
Leadership
Careers
Contact Us
About Lucence
Leadership
Careers
Contact Us

Home
Solutions
Screening and Health Risk Assessment
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Treatment Selection
LiquidHALLMARK® & LiquidMARK™
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
Hereditary Risk Assessment
Lumi Series
Treat Response Monitoring
LucenceMONITOR™
Screening and Health Risk Assessment
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Treatment Selection
LiquidHALLMARK® & LiquidMARK™
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
Hereditary Risk Assessment
Lumi Series
Treat Response Monitoring
LucenceMONITOR™
Communities
Primary Care Doctors
Oncologists
Patients
Investors
Primary Care Doctors
Oncologists
Patients
Investors
Knowledge Center
News & Updates
Clinical Insights
Publications
Patient Stories
Webinars
Case Studies
News & Updates
Clinical Insights
Publications
Patient Stories
Webinars
Case Studies
About Lucence
About Lucence
Leadership
Careers
Contact Us
About Lucence
Leadership
Careers
Contact Us

Solutions
Screening and Health Risk Assessment
LucenceINSIGHT™
CardioHemeRISK™
Treatment Selection
LiquidHALLMARK®
LiquidHALLMARK® CSF
Communities
Communities
Oncologists
Patients
Insurers
Investors
Knowledge Center
Knowledge Center
News & Updates
Clinical Insights
Publications
Patient Stories
Webinars
Case Studies
About Us
About Us
About Lucence
Leadership
Careers
Contact Us

Solutions
Screening & Health Risk Assessment
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Treatment Selection
LiquidHALLMARK® & LiquidMARK™
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
Hereditary Risk Assessment
Lumi Series
Treatment Response Monitoring
LucenceMONITOR™
Treatment Selection
LiquidHALLMARK®
LiquidHALLMARK® CSF
Communities
Communities
Oncologists
Patients
Insurers
Investors
Communities
Primary Care Doctors
Oncologists
Patients
Investors
Knowledge Center
Knowledge Center
News & Updates
Clinical Insights
Publications
Patient Stories
Webinars
Case Studies
About Us
About Us
About Lucence
Leadership
Careers
Contact Us

All Posts
Case Studies
Press Releases

All Posts

Copy of Lorem ipsum dolor sit amet

Copy of Lorem ipsum dolor sit amet

Copy of Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet

Darius Baker

Oct 29, 20251 min read

Foobar

Foobar

Foobar

Lorem ipsum dolor sit amet

-

Oct 25, 20251 min read

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet

-

Oct 24, 20251 min read

Our Presence

Palo Alto

3520 W Bayshore Road, Palo Alto, CA 94303
Tel: (888) 582 3623

Singapore

211 Henderson Road, #04-01/02,
Henderson Industrial Park, S159552
Tel: (65) 6909 0390 | Fax: (65) 6725 0590

Hong Kong

Room 70, 14/F, Pioneer Centre, 750 Nathan Road, Yau Tsim Mong District, Kowloon, Hong Kong
Tel: (852) 5182 7199 | Fax: (852) 3012 9866

Subscribe for Updates

Email

Contact Us

Reach us at inquiry@lucence.com
or via our contact form here.

Follow Us

© 2026 Lucence Health Inc. All rights reserved. All logos and trademarks are the property of Lucence or their respective owners.

Licenses | Privacy Policy | Order Terms | Website Terms of Use | Legal

bottom of page